Amedisys Management
Management criteria checks 1/4
Amedisys' CEO is Richard Ashworth, appointed in Apr 2023, has a tenure of less than a year. directly owns 0.34% of the company’s shares, worth $10.38M. The average tenure of the management team and the board of directors is 1.5 years and 4.3 years respectively.
Key information
Richard Ashworth
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | less than a year |
CEO ownership | 0.3% |
Management average tenure | 1.5yrs |
Board average tenure | 4.3yrs |
Recent management updates
Recent updates
Is Amedisys, Inc. (NASDAQ:AMED) Trading At A 41% Discount?
Apr 10Does Amedisys (NASDAQ:AMED) Have A Healthy Balance Sheet?
Feb 25Amedisys (NASDAQ:AMED) Will Be Hoping To Turn Its Returns On Capital Around
Feb 10At US$83.54, Is It Time To Put Amedisys, Inc. (NASDAQ:AMED) On Your Watch List?
Jan 03A Look At The Fair Value Of Amedisys, Inc. (NASDAQ:AMED)
Dec 16Capital Allocation Trends At Amedisys (NASDAQ:AMED) Aren't Ideal
Nov 12Is Now The Time To Look At Buying Amedisys, Inc. (NASDAQ:AMED)?
Sep 19An Intrinsic Calculation For Amedisys, Inc. (NASDAQ:AMED) Suggests It's 38% Undervalued
Sep 04Amedisys: ROIC, Tangible Book Value Each Softening
Aug 24Slowing Rates Of Return At Amedisys (NASDAQ:AMED) Leave Little Room For Excitement
Aug 04Amedisys profit beats by $0.24, revenue misses by $25.23M, 2022 guidance below estimates
Jul 27We Think Amedisys (NASDAQ:AMED) Can Stay On Top Of Its Debt
Jul 20At US$115, Is It Time To Put Amedisys, Inc. (NASDAQ:AMED) On Your Watch List?
Jun 04Returns On Capital At Amedisys (NASDAQ:AMED) Have Stalled
May 05Is Amedisys, Inc. (NASDAQ:AMED) Trading At A 40% Discount?
Apr 20Does Amedisys (NASDAQ:AMED) Deserve A Spot On Your Watchlist?
Apr 06Is Amedisys (NASDAQ:AMED) A Risky Investment?
Feb 20Amedisys (NASDAQ:AMED) Shareholders Will Want The ROCE Trajectory To Continue
Jan 19Should You Be Adding Amedisys (NASDAQ:AMED) To Your Watchlist Today?
Dec 03These 4 Measures Indicate That Amedisys (NASDAQ:AMED) Is Using Debt Safely
Nov 18Amedisys (NASDAQ:AMED) Could Easily Take On More Debt
Aug 18Calculating The Fair Value Of Amedisys, Inc. (NASDAQ:AMED)
Jul 23Amedisys: Strategic Contessa Acquisition Underpins The Home Healthcare Growth Opportunity
Jul 18Under The Bonnet, Amedisys' (NASDAQ:AMED) Returns Look Impressive
Jun 28It Looks Like Shareholders Would Probably Approve Amedisys, Inc.'s (NASDAQ:AMED) CEO Compensation Package
Jun 02Should You Be Adding Amedisys (NASDAQ:AMED) To Your Watchlist Today?
May 24Calculating The Fair Value Of Amedisys, Inc. (NASDAQ:AMED)
Apr 14CEO
Richard Ashworth (48 yo)
less than a year
Tenure
Mr. Richard M. Ashworth served as Director at Tivity Health, Inc. since June 1, 2020 until April 2023 and had been its President since June 1, 2020 and served as its Chief Executive Officer since June 1, 2...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Executive VP | 6.4yrs | US$4.16m | 0.067% $ 2.0m | |
Chief Information Officer | 7.3yrs | US$1.19m | 0.033% $ 981.4k | |
Chief Compliance Officer | 4.5yrs | US$899.96k | no data | |
Chief Strategy Officer | no data | US$1.90m | 0.0061% $ 183.3k | |
President | less than a year | no data | 0.34% $ 10.4m | |
Chief Accounting Officer & Principal Accounting Officer | less than a year | no data | 0.0096% $ 289.3k | |
CTO & Senior VP of Business Operations Systems | no data | no data | no data | |
Senior VP | 1.4yrs | no data | no data | |
VP of Marketing & Communications & Media Relations | no data | no data | no data | |
Chief People Officer | 1.5yrs | no data | 0.00029% $ 8.7k | |
Senior Vice President of Development | no data | no data | no data |
1.5yrs
Average Tenure
50yo
Average Age
Experienced Management: AMED's management team is not considered experienced ( 1.5 years average tenure), which suggests a new team.
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | less than a year | no data | 0.34% $ 10.4m | |
Chairman | 9.3yrs | US$4.08m | 1.34% $ 40.2m | |
Independent Director | 8.9yrs | US$265.04k | 0.054% $ 1.6m | |
Independent Director | 4.3yrs | US$275.04k | 0.0098% $ 295.3k | |
Independent Director | 4.3yrs | US$261.29k | 0.0067% $ 203.2k | |
Lead Independent DIrector | 7.9yrs | US$277.54k | 0.029% $ 867.9k | |
Independent Director | 7.9yrs | US$265.04k | 0.0083% $ 250.8k | |
Independent Director | 4.3yrs | US$265.04k | 0.0098% $ 295.3k | |
Independent Director | 3.3yrs | US$250.04k | 0.0030% $ 90.9k |
4.3yrs
Average Tenure
62yo
Average Age
Experienced Board: AMED's board of directors are considered experienced (4.3 years average tenure).